Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03901573
Title High-Risk Skin Cancers With Atezolizumab Plus NT-I7
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NeoImmuneTech
Indications

skin squamous cell carcinoma

Merkel cell carcinoma

melanoma

Therapies

Atezolizumab + NT-I7

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Not yet recruiting Boston Massachusetts 02215 United States Details
Washington University Recruiting Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
Mt Sinai Recruiting New York New York 10029 United States Details
Cleveland Clinic Recruiting Cleveland Ohio 44106 United States Details
Providence Portland Medical Center Recruiting Portland Oregon 97213 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field